The new cancer drug operates through a novel mechanism targeting specific cancer cell pathways. Unlike traditional chemotherapy, which affects both cancerous and healthy cells, this drug aims to minimize damage to non-cancerous tissues. It achieves this by inhibiting certain proteins or enzymes essential for cancer cell survival and proliferation.
